HOME >> MEDICINE >> NEWS
Lancet study: Pfizer's Vfend equals two-drug candidemia regimen, with fewer serious side effects

New York, November 4, 2005 Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen. This is based on a study published in The Lancet in October.

The study highlights Vfend, Pfizer's antifungal treatment, as an important treatment option for candidemia in nonneutropenic patients (those who do not have low white blood cell counts). Vfend is the only treatment available in oral and IV formulations that is approved as first-line therapy against both mould and yeast infections.

"This study proves the effectiveness of Vfend for the treatment of candidemia, an often-deadly fungal infection for which we need multiple treatment options," said Dr. Jack D. Sobel, study investigator and professor and chief of the Division of Infectious Diseases at Wayne State University School of Medicine. "Because of Vfend's broad spectrum of activity against infections caused by yeasts and moulds, it is a good first-choice treatment option for immunocompromised patients who are at risk for those types of infection."

Candidemia is a systemic fungal infection in the blood that can lead to other body organ infections. Surgical patients and patients with compromised immune systems are at high risk for candidemia.

This study was the first ever to compare Vfend versus amphotericin B followed by fluconazole, both of which are approved treatments for candidemia. However, amphotericin B is commonly associated with toxic effects, including a risk of kidney failure. In addition, the prevalence of fluconazole-resistant Candida is increasing.

The study used a non-inferiority study design in which the trial objective was to evaluate the comparability of differing treatment options. Results showed that the treatment regimens were comparable in terms of effectiveness, i
'"/>


4-Nov-2005


Page: 1 2 3

Related medicine news :

1. Rotavirus vaccine papers win the Lancets Paper of the Year 2006
2. Lancets coverage of the World Health Organization Director-General election
3. The Lancet calls for transparency in the selection of a new executive director for the global fund
4. The Lancet calls on research community to address neglected disease that causes heart failure
5. AIDS debate launches Lancet podcast
6. The Lancet goes red to support fight against AIDS
7. Scientists describe face transplant technique in the Lancet
8. Lancet and Mexican government to hold meeting on health-system reform
9. Launch of the Lancet Asia Medical Forum
10. The Lancet Neonatal Series at one year of age has anything changed?
11. Representation from 41 countries confirmed for the Lancet Asia Medical Forum on Pandemic Influenza

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... IRVINE, Calif. (PRWEB) , ... August 31, 2020 ... ... providers of business support services to dental groups in the United States, today ... serving the community of Beaumont, CA. , Patients will enjoy convenient hours, ...
(Date:8/31/2020)... ... 2020 , ... In an effort to give back to the community in ... each hotel room booked with a special new rate code to benefit children and ... effective immediately. Donations will be applied to any room type, any time, now ...
(Date:8/29/2020)... ... ... When professor and author Randy Pausch was diagnosed with pancreatic cancer, he accepted his ... however, he put together a final lecture in Carnegie Hall in which he offered ... and turned it into something that inspired millions of people worldwide. This inclination to ...
(Date:8/28/2020)... ... August 28, 2020 , ... The 15 ... customized Lighthouse Health & Wellness mobile app and web-portal. NCPCV received a 2020 ... Foundation awards grants each year to organizations, such as Destination Imagination, which support ...
(Date:8/28/2020)... ... , ... Ziegler, a specialty investment bank, is pleased to ... a tech-enabled behavioral health and well-being solutions provider. , Synchronous Health, a ... (AI) to increase access and quality of behavioral health services, and Adventist Health, ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... ... ... While coronavirus cases continue to increase across the country, blood drives are ... Because about 80% of blood donations are made at drives hosted by these groups, ... hosts to ensure blood products are readily available for patients. , Those interested ...
(Date:8/31/2020)... ... 31, 2020 , ... Continuing on its rapid national expansion ... and deodorization provider - is proud to announce it has opened doors in ... and residents throughout the area. , Germinator provides a 100% safe and non-toxic ...
(Date:8/27/2020)... CONSHOHOCKEN, Pa. (PRWEB) , ... August 27, 2020 ... ... and care coordination software, today announced the successful completion of their 2020 System ... as well as their HITRUST® interim assessment and MARS-E compliance assessment. These achievements ...
Breaking Medicine Technology:
Cached News: